The wealthy entrepreneur: I want to support millions of employees!.

Chapter 1067 Transnational and International Relations! We can't block the path to wealth for shareholders, management, and employees!

He definitely prefers to partner with a major American healthcare company!

The development of bispecific antitumor drugs is currently the hottest innovative drug track in the world, and many innovative drug companies at home and abroad are conducting research and development in this area.

Perhaps other companies can develop new products with therapeutic effects comparable to or even exceeding those of LM8012!

The LM8012 is only relatively advanced at this stage!

LM8012 is not some panacea; he and the company developed it simply to make money!
The key is to cooperate with international medical giants as soon as possible to recoup some funds in the early stage, help other R&D projects of the company, speed up the clinical trial of LM8012, and get international medical giants to help LM8012 pass the approval of various countries as soon as possible. The goal is to launch the product in overseas countries, occupy the market and make money and get the share!
As for the company's R&D acceleration buff, it is indeed very fast, but that doesn't mean it can't be caught up by other leading domestic and international innovative drug companies.

In the global innovative drug market, the United States accounts for about 65%-72%, while China accounts for about 3%. Currently, the United States is dominant in the field of biotechnology because it allocates 20% of its GDP to this purpose, while China only allocates 5%.

A stark comparison reveals that the same innovative drug from a Chinese company sells for 20-30 times more in the US than it does in China… Therefore, no matter what, RomiBio cannot give up the US market!
Without the support of a major US healthcare company, RomiBio would need at least five years to enter the US market through the formal review process... This is just the surface level, because historically, the success rate of domestic innovative drugs entering the US market independently is less than 2%, and many financially strong leading innovative drug companies in China have no choice but to cooperate.

Who knows what underhanded tactics those American medical companies might pull during the review process? Coupled with the current trade frictions, it will definitely become even more difficult for domestically developed innovative drugs to be independently approved and listed in the United States.

Therefore, partnering with American healthcare giants is currently the most profitable way for Su Yang and his company to monetize their assets!
"Boss, maybe our company can go public!"

Su Yang's eyes narrowed, then he asked in a light tone, "Do you also want to take your company public?"

“Of course!” Song Mingliang said with a smile, “Isn’t that what everyone dreams of, including Professor Su? The boss doesn’t want to make a fortune!”

"Yes! Of course I want to!" Su Yang encouraged with a smile, "Then you should do your best!"

"Don't worry, boss, I'll definitely give it my all!"

"Okay, I won't forget your contribution!"

"thank you boss!"

Song Mingliang's tone was filled with uncontrollable joy, which even Su Yang, who was in Hong Kong, could clearly feel!
"One more thing!" Su Yang thought for a moment and then said, "We can consider registering an overseas company, or changing the company's registered address overseas. If we want to cooperate with international medical giants, we must take into account the national conditions of both countries. You need to come up with a plan for this!"

"Good boss!"

Song Mingliang understood immediately after Su Yang's reminder: Luo Mi Bio had made plans for foreign capital withdrawal in recent years!
After hanging up the phone, Su Yang took a deep breath... It seems this company is about to go public!
If he can help the company secure that multi-billion dollar order, RomiBio will definitely become a star innovative drug company in China and will already be eligible for listing!

Although Su Yang was a little reluctant to let the company go public, feeling that it would be inconvenient for him to operate the business after the company went public, this was, after all, everyone's opinion!
Although Su Yang controls the majority of the company's shares, the other minority shareholders, management, and technical backbone, including the company's most prestigious and R&D-capable founder Su Yaohui, as well as other technical talents, are also an indispensable part of the company!

If everyone is hoping the company can go public, then he really can't stop it!
He can't stand in the way of his employees making money!

"Let's go public then!"

After a slight hesitation, Su Yang made his decision. It wasn't like he had never managed a listed company before!

Moreover, managing Gaoxing Retail is significantly more difficult than managing Luomi Bio.

Becoming a listed company would indeed be more advantageous for RomiBio. If it can take on a large portion of the tens of billions of dollars, its initial valuation will at least not be too bad.

They can also use shareholders' money for research and development, reducing the burden and risks on the company and Su Yang.

Having a listed high-tech company would also enhance Su Yang's influence!

The only downside might be the need to publish financial reports.

However, this wasn't a problem for Su Yang. Romi Bio wasn't a high-end retailer. It belonged to the high-tech industry, and once he secured that deal, the overall profit would still be substantial.

This means he can easily offer his employees decent salaries and benefits without having to spend his own money!
As for the issue of equity, since the last upgrade, he no longer needs more than 50% controlling stake, and his equity is already concentrated enough... Once Su Yang understood this, he became happy!

In the future, this company won't need to subsidize itself. If it needs money, it can get financing. Just leaving it there will generate profits continuously, and it can also distribute dividends every year. It sounds wonderful!
The reason for having a company register overseas, or directly changing the company's registration overseas, is also due to practical interests.

He had done a business analysis. If he wanted to cut out the European intermediary, Escare, and cooperate directly with Bristol-Myers Squibb (BMS) in the United States, he would have to consider the friction between the two countries!
This is to avoid geopolitical and policy risks, and even BMS has to take it seriously!

Su Yang's actions are certainly permitted, as long as they are approved by the domestic authorities.

Many innovative drug companies consider changing their registered headquarters address to the Cayman Islands or Europe, or establishing overseas subsidiaries, in order to facilitate financing, listing, cooperation with international medical giants, or to avoid taxes.
Su Yang wasn't entirely an expert; he needed to make a decision based on Song Mingliang's plan and the company's actual situation.
"The boss seems very happy!"

Hua Jing stood in front of his office door, holding a large stack of documents, and smiled.

"We've received good news from a company!" Su Yang said with a smile. "I'm really in a good mood!"

After finishing some tasks, he received an invitation to a banquet from the Yang family.

Although the Yang family in Hong Kong has declined significantly in recent years, especially after the real estate market entered a downturn, their debt problems have become increasingly serious.

But after all, they are a long-established local family. Even a broken ship has some nails left, and their connections are still very strong. This is the first time they have invited him, so Su Yang thought about it and decided to go!
In the evening, Su Yang tidied himself up a bit, then grabbed one of the company drivers and had him take him to the private club where the banquet was being held!

"Chairman Su, welcome!"

As soon as he arrived at the clubhouse entrance, Zheng Zhigang greeted him with a smile!

He was very impressed with Su Yang, not only because he was the chairman of Gaoxing Retail and had a net worth of tens of billions, but also because of recent rumors that Su Yang's private equity firm, Yuanshi, had made tens of billions by shorting US stocks.

He asked his friends in the United States and mainland China, and the matter has been almost confirmed!
Moreover, the other party's funds have not been withdrawn; they have simply reversed course and gone long!

Local Hong Kong businessmen are most enthusiastic about finance and real estate.

However, most of their financial businesses are confined to Hong Kong, and there are very few who dare to invest tens of billions of dollars in the US stock market!
"I'm just here to join in the fun!"

"Welcome, please come in. I'm currently busy here!"

"Okay! Don't worry about me, I can go in by myself!"

Accompanied by a waiter, Su Yang arrived at the lobby of the private club and saw several familiar faces.

Luo Yingqi even stood up and waved to him: "Chairman Su, over here!"

"Ok!"

Upon seeing a familiar face, Su Yang smiled and walked over!

As soon as he sat down next to Luo Yingqi, he said with a resentful look in his eyes, "I invited you out yesterday, but you wouldn't come... Now that Chairman Yang has invited you, you've come?"

"Sigh~ Yesterday was really busy!"

(End of this chapter)